-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Current Results with BITEs and Bispecific Antibodies in Lymphoid Malignancies

Program: Scientific Workshops @ ASH
Session: Immune Engaging Molecules in the Management of Lymphoid Malignancies
Wednesday, December 2, 2020, 7:05 AM-8:20 AM

Max S. Topp, MD

Universitätsklinikum Würzburg, Würzburg, Germany

Disclosures: No relevant conflicts of interest to declare.

See more of: Immune Engaging Molecules in the Management of Lymphoid Malignancies
See more of: Scientific Workshops @ ASH
Previous Presentation | Next Presentation >>